Tag: graft-versus-host disease (GVHD)
#VisualAbstract: Ruxolitinib improved glucocorticoid-refractory chronic graft-versus-host disease
1. Ruxolitinib was shown to significantly improve failure-free survival for glucocorticoid-refractory chronic graft-versus-host disease (GVHD) compared to control therapy. 2. ...
Ruxolitinib improved glucocorticoid-refractory chronic graft-versus-host disease
1. Ruxolitinib was shown to significantly improve failure-free survival for glucocorticoid-refractory chronic graft-versus-host disease (GVHD) compared to control therapy. 2. ...
![Engineered stem cells mitigate liver damage caused by radiation [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/Human_embryonic_stem_cells-350x250.png)
Sitagliptin may reduce acute graft-versus-host disease following allogeneic stem-cell transplantation
1. While standard prophylaxis regimens against acute graft-versus-host disease (GVHD) are ineffective in a substantial portion of patients, less than ...
Improvements in survival after allogeneic hematopoietic cell transplantation have continued over the past decade
1. In this retrospective study comparing patients who received first allografts in 2003-2007 versus 2013-2017, significant reductions in mortality were ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
